Insamo AB
Pioneering scalable machine learning for novel oral peptide drug discovery.
Overview
- 1–4
- Employees
- 1–2.5M SEK
- Revenue
- 2021
- Founded
Key Decision Makers
Tim Craven
CEO
Glen McIntyre
COO
Toby Passioura
CSO
Description
Insamo is a biotechnology company dedicated to transforming the landscape of drug discovery. They specialize in pioneering the development of novel membrane-permeable and orally available cyclic-peptides. Their core mission is to create new therapeutic solutions for some of the most challenging dise...